Maccura Biotechnology Co Ltd Market Cap ($801.64 Million)
Market Cap & Net Worth: Maccura Biotechnology Co Ltd (300463)
Maccura Biotechnology Co Ltd market cap. Maccura Biotechnology Co Ltd (SHE:300463) has a market capitalization of $801.64 Million (CN¥5.48 Billion) as of November 6, 2026. Listed on the SHE stock exchange, this China-based company holds position #9602 globally and #2399 in its home market, demonstrating a -1.52% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Maccura Biotechnology Co Ltd's stock price CN¥9.06 by its total outstanding shares 604666624 (604.67 Million). Also see Maccura Biotechnology Co Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
Maccura Biotechnology Co Ltd Market Cap History (2015–2026)
Maccura Biotechnology Co Ltd market cap history from 2015 to 2026. Data shows change from $3.17 Billion to $801.64 Million (-9.22% CAGR). Check current stock price of Maccura Biotechnology Co Ltd for real-time trading data and today's change.
Maccura Biotechnology Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Maccura Biotechnology Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Maccura Biotechnology Co Ltd net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.46x
Maccura Biotechnology Co Ltd's market cap is 0.46 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.99 Billion | $1.49 Billion | $312.02 Million | 1.34x | 6.38x |
| 2017 | $1.95 Billion | $1.97 Billion | $374.13 Million | 0.99x | 5.22x |
| 2018 | $1.20 Billion | $2.69 Billion | $444.93 Million | 0.45x | 2.69x |
| 2019 | $2.22 Billion | $3.22 Billion | $525.26 Million | 0.69x | 4.23x |
| 2020 | $3.85 Billion | $3.70 Billion | $793.92 Million | 1.04x | 4.85x |
| 2021 | $2.44 Billion | $3.98 Billion | $956.60 Million | 0.61x | 2.55x |
| 2022 | $1.48 Billion | $3.61 Billion | $708.18 Million | 0.41x | 2.09x |
| 2023 | $1.32 Billion | $2.90 Billion | $312.62 Million | 0.45x | 4.21x |
| 2024 | $1.17 Billion | $2.55 Billion | $126.81 Million | 0.46x | 9.21x |
| 2025 | $990.11 Million | $2.17 Billion | -$35.83 Million | 0.46x | N/A |
Competitor Companies of 300463 by Market Capitalization
Companies near Maccura Biotechnology Co Ltd in the global market cap rankings as of November 6, 2026. Also see total assets of Maccura Biotechnology Co Ltd for a full breakdown of the balance sheet.
Key companies related to Maccura Biotechnology Co Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #86 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #138 globally with a market cap of $165.94 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #479 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #505 globally with a market cap of $53.86 Billion USD ( CN¥368.05 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #86 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $706.16 |
| #138 | Danaher Corporation | NYSE:DHR | $165.94 Billion | $234.93 |
| #479 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $391.03 |
| #505 | WuXi AppTec Co Ltd | SHG:603259 | $53.86 Billion | CN¥148.81 |
Market Capitalization of Maccura Biotechnology Co Ltd (2015–2026)
Market capitalization of Maccura Biotechnology Co Ltd from 2015 to today. Between 2015 and today, Maccura Biotechnology Co Ltd's market cap moved from $3.17 Billion to $ 801.64 Million, with a yearly change of -9.22%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥801.64 Million | -19.03% |
| 2025 | CN¥990.11 Million | -15.23% |
| 2024 | CN¥1.17 Billion | -11.21% |
| 2023 | CN¥1.32 Billion | -11.10% |
| 2022 | CN¥1.48 Billion | -39.24% |
| 2021 | CN¥2.44 Billion | -36.78% |
| 2020 | CN¥3.85 Billion | +73.34% |
| 2019 | CN¥2.22 Billion | +85.87% |
| 2018 | CN¥1.20 Billion | -38.78% |
| 2017 | CN¥1.95 Billion | -1.93% |
| 2016 | CN¥1.99 Billion | -37.07% |
| 2015 | CN¥3.17 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Maccura Biotechnology Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $801.64 Million USD |
| MoneyControl | $801.64 Million USD |
| MarketWatch | $801.64 Million USD |
| marketcap.company | $801.64 Million USD |
| Reuters | $801.64 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Maccura Biotechnology Co Ltd
Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such a… Read more